Pay for Performance Drugs

Check out this article over at the NY Times. The article describes various different trial programs where national health services or insurers and pharmaceutical companies are making the drug pricing contingent on results (i.e. if jane doe dies of breast cancer jane doe's insurer does not have to pay for brand X cancer pills).